NEW YORK (GenomeWeb News) – The Red Cross Blood Transfusion Service of Upper Austria said today it has been accredited by the European Federation for Immunogenetics for the use of human leukocyte antigen tests based on next-generation sequencing on Roche's GS Junior system.

The method provides more precise and rapid tissue-typing and donor selection for stem cell transplants, the laboratory said. The HLA testing had been use only for research, but will now be available as "a standard routine diagnostic procedure," it added.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.

Apr
27
Sponsored by
SeraCare

This webinar is the third in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.

May
09
Sponsored by
SeraCare

This webinar is the last in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic.